Dietary recommendations for patients with nonalcoholic fatty liver disease

Przeglad Gastroenterologiczny

Volumn 9, Issue 1, 2014, Pages 18-23

  Kargulewicz, Angelika ^a   Stankowiak Kulpa, Hanna ^a   Grzymisałwski, Marian ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Diet; Dietary recommendations; Nonalcoholic fatty liver disease

Indexed keywords

CAFFEIC ACID; COUMARIC ACID; FATTY ACID; FISH OIL; FRUCTOSE; FRUCTOSE OLIGOSACCHARIDE; GLUCOSE; GLUTAMATE SODIUM; HYDROXYTYROSOL; INSULIN; LIGNAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OLEUROPEIN; OLIVE OIL; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHENOL DERIVATIVE; POLYUNSATURATED FATTY ACID; PREBIOTIC AGENT; PROTOCATECHUIC ACID; RAPESEED OIL; SATURATED FATTY ACID; SQUALENE; TRANS FATTY ACID; TRIACYLGLYCEROL; VANILLIC ACID; VERY LOW DENSITY LIPOPROTEIN;

AVOCADO; BEVERAGE; CALORIC INTAKE; CARBOHYDRATE INTAKE; DEVELOPED COUNTRY; DIET THERAPY; DIETARY FIBER; FAT INTAKE; FRUIT; HUMAN; LIFESTYLE MODIFICATION; NONALCOHOLIC FATTY LIVER; NUT; NUTRITIONAL SUPPORT; PROTEIN CONTENT; PROTEIN INTAKE; REVIEW; SOFT DRINK; SUNFLOWER; VEGETABLE; WEIGHT REDUCTION;

EID: 84896289100     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2014.40845     Document Type: Review

References (32)

1. York LW, Puthalapattu S, Wu GY. Nonalcocholic fatty liver disease and low-carbohydrate diets. Annu Rev Nutr 2009; 29: 365-79.
2. Bellentani S, Grave RD, Suppini A. Behavior therapy for non-alcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 2008; 47: 746-54. (Pubitemid 351280743)
3. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006; 82: 315-22. (Pubitemid 43780662)
4. Dudzik D, Knaś M, Borzym-Kluczyk M, et al. Nonalcoholic steatohepatitis (NASH) - pathogenesis, diagnosis, treatment [Polish]. Med Sci Hepatol 2008; 8: 48-58.
5. Raszeja-Wyszomirska J, Ławniczak M, Marlicz W, et al. Nonalcoholic fatty liver disease (NAFLD) - new insight [Polish]. Pol Merkuriusz Lek 2008; 24: 568-71.
6. Jarosz M, Respondek W. Dietary recommendations and lifestyle [Polish]. In: Nonalcoholic fatty liver disease. Jarosz M (ed.) PZWL, Warsaw 2010; 45-56.
7. Bayol SA, Simbi BH, Fowkes RC. A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic fatty liver disease in rat offspring. Endocrinology 2010; 151: 1451-61.
8. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007; 86: 285-300. (Pubitemid 47256910)
9. Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression oh nonalcoholic fatty liver disease. J Nutr Biochem 2008; 19: 567-76.
10. Assy N, Nassar F, Nasser G, et al. Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterology 2009; 15: 1809-15.
11. Vos MB, McClein CJ. Nutrition and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008; 10: 308-15.
12. Leclercq IA, Horsmans Y. Nonalcoholic fatty liver disease: the potential role of nutrition management. Curr Opin Clin Nutr Metab Care 2008; 11: 766-73.
13. Byrne C, Olufadi R, Bruce KD. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci 2009; 116: 539-64.
14. Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liv Dis 2008; 40: 194-9. (Pubitemid 351181793)
15. Pickova J. Importance of knowledge on lipid composition of foods to support development towards consumption of higher levels of n-3 fatty acids via freshwater fish. Physiol Res 2009; 58: 39-45.
16. Moschen AR, Tilg H. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2008; 11: 620-5.
17. Nseir W, Nassar F, Assy N. Soft drinks consumption and non-alcoholic fatty liver disease. World J Gastroenterol 2010; 16: 2579-88.
18. Dhingra R, Sullivan L, Jacques PF. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in community. Circulation 2007; 116: 480-8. (Pubitemid 47450256)
19. Abid A, Taha O, Nseir W. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009; 51: 918-24.
20. Le KA, Bortolotti M. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2008; 11: 477-82.
21. Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009; 89: 1751-9.
22. Cani PD, Knauf C, Iglesias MA. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006; 55: 1484-90. (Pubitemid 44195391)
23. Arciero PJ, Gentile CL, Pressman R, et al. Moderate protein intake improves total and regional body composition and insulin sensitivity in overweight adults. Metabolism 2008; 57: 757-65. (Pubitemid 351697906)
24. Krishna VN, Karthika D, Surya DM, et al. Analysis of monosodium l-glutamate in food products by high-performance thin layer chromatography. J Young Pharm 2010; 2: 297-300.
25. Gertig H, Duda G. Allowed substances added to food products [Polish]. In: Law in a food industry. Grtig H, Duda G (eds.). PZWL, Warsaw 2004; 209-10.
26. Collison KS, Maqbool Z, Inglis AL, et al. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res 2009; 50: 1521-37.
27. Nimatha MW, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48: 104-12.
28. Ciborowska H. Low-calorie diet [Polish]. In: Dietetics. Nutritional therapy for healthy and ill patients. Ciborowska H, Rudnicka A (eds.). PZWL, Warsaw 2007; 280-9.
29. Loria P, Adinolfi LE, Bellentani S, et al. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. Dig Liv Dis 2010; 42: 272-82.
30. Ciborowska H, Rudnicka A. Nutrition of human with elements of biochemistry [Polish]. In: Dietetics. Nutritional therapy for healthy and ill patients. Ciborowska H, Rudnicka A (eds.). PZWL, Warsaw 2007; 280-9.
31. Fołta M, Bartoń H, Paśko P, et al. Oxidative stress and metabolic disturbances in a high-fructose rat model [Polish]. Bromat Chem Toksykol 2009; 3: 842-7.
32. Raszeja-Wyszomirska J, Safranow K, Szynkowska A. Secretory phospholipase A2 activity is linked to hipercholesterolemia and gender in non-alcoholic fatty liver disease individuals. Prz Gastroenterol 2013; 8: 172-5.